Cullinan Therapeutics
$18.13
17
-$0.25-1.36% Friday 19:59
+$0.12+0.66%Friday 21:18After hours
Statistics
Day High
18.14
Day Low
18.11
52W High
19.43
52W Low
5.68
Volume
19,971
Avg. Volume
-
Mkt Cap
1.11B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
6AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-1.07
-0.94
-0.82
-0.69
Expected EPS
-0.799375
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-219.88MNet Income
Analyst Ratings
33.60Average Price Target
The highest estimate is 38.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CGEM. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Array Technologies
ARRY
Mkt Cap1.1B
Agios Pharmaceuticals
AGIO
Mkt Cap2.22B
Incyte
INCY
Mkt Cap23.35B
Exelixis
EXEL
Mkt Cap13.77B
Novartis
NVS
Mkt Cap305.1B
Bristol-Myers Squibb
BMY
Mkt Cap118.71B
AMGEN
AMGN
Mkt Cap201.93B
About
Cullinan Therapeutics, Inc. operates as a biopharmaceutical firm actively advancing its therapeutic candidates through clinical trials. This company is focused on developing innovative treatments primarily for cancer, including those that leverage the immune system (immuno-oncology). Its current roster of investigational drugs comprises CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. Patrick A. Baeuerle founded the organization on September 15, 2016, and it is presently headquartered in Cambridge, Massachusetts.
Show more...
CEO
Mr. Nadim Ahmed M.S.
Employees
111
Country
United States
ISIN
US2300311063
Listings
0 Comments
Share your thoughts
FAQ
What is Cullinan Therapeutics stock price today?▼
The current price of CGEM is $18.13 USD — it has decreased by -1.36% in the past 24 hours. Watch Cullinan Therapeutics stock price performance more closely on the chart.
What is Cullinan Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Cullinan Therapeutics stocks are traded under the ticker CGEM.
Is Cullinan Therapeutics stock price growing?▼
CGEM stock has risen by +2.84% compared to the previous week, the month change is a +32.34% rise, over the last year Cullinan Therapeutics has showed a +135.45% increase.
What is Cullinan Therapeutics market cap?▼
Today Cullinan Therapeutics has the market capitalization of 1.11B
When is the next Cullinan Therapeutics earnings date?▼
Cullinan Therapeutics is going to release the next earnings report on August 06, 2026.
What were Cullinan Therapeutics earnings last quarter?▼
CGEM earnings for the last quarter are -0.75 USD per share, whereas the estimation was -0.84 USD resulting in a +10.27% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cullinan Therapeutics revenue for the last year?▼
Cullinan Therapeutics revenue for the last year amounts to 0 USD.
What is Cullinan Therapeutics net income for the last year?▼
CGEM net income for the last year is -219.88M USD.
How many employees does Cullinan Therapeutics have?▼
As of July 12, 2026, the company has 111 employees.
In which sector is Cullinan Therapeutics located?▼
Cullinan Therapeutics operates in the Health & Wellness sector.
When did Cullinan Therapeutics complete a stock split?▼
The last stock split for Cullinan Therapeutics was on August 31, 2009 with a ratio of 2:1.
Where is Cullinan Therapeutics headquartered?▼
Cullinan Therapeutics is headquartered in Cambridge, United States.